Pentetate Calcium Trisodium Yb-169

CHEMBL1200698 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
666.3 g/mol
LogP
Phase
4

A radioactive ytterbium-169 labeled form of calcium DTPA, used in nuclear medicine cisternography to image the cerebrospinal fluid spaces and assess flow dynamics in the brain and spinal canal.

분자량

666.2900 g/mol

TPSA

210.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Ca+2].[169Yb]

InChI

InChI=1S/C14H23N3O10.Ca.3Na.Yb/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;;/q;+2;3*+1;/p-5/i;;;;;1-4

Molecular Formula

C14H18CaN3Na3O10Yb

HBD / HBA

- / 13

회전 가능 결합

11

무거운 원자

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A radioactive ytterbium-169 labeled form of calcium DTPA, used in nuclear medicine cisternography to image the cerebrospinal fluid spaces and assess flow dynamics in the brain and spinal canal.

Yes, Pentetate Calcium Trisodium Yb-169 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200698. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 49800014. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.